seed 168 155 612 569 57 75 267 296
and traits 119 85 325 280 72 44 171 146
Genomics $742 $531 $4,964 $3,978 $359 $248 $3,014 $2,433
($ in millions) Earnings Before Interest & Taxes (EBIT)
Fourth Fourth Fiscal Fiscal
Seeds and Genomics Quarter Quarter Year Year
2007 2006 2007 2006
EBIT (For a reconciliation of
EBIT, see note 2.) $(397) $(228) $905 $794
Unusual Items Affecting EBIT
DPL Acquired In-Process R&D $(186) None $(186) None
Income (Loss) on
discontinued operations $50 $(6) $45 $6
Pre-tax Cumulative Effect of
Change in Accounting
Principle None $(5) None $(5)
The Seeds and Genomics segment consists of the company's global seeds and related traits business, and genetic technology platforms.
Sales for Monsanto's Seeds and Genomics segment were $742 million for the fourth quarter of fiscal year 2007, or 40 percent higher than sales in the same period last year.
During the fourth quarter of fiscal year 2007, the company realized increased revenues from its corn seed and traits business. The key factors for growth included a successful conclusion to the seed and traits season in the United States and strong farmer demand for the company's corn seed products in Argentina and Brazil.
Monsanto realized record segment sales of $5 billion for fiscal year
2007 which were 25 percent higher compared with sales last fiscal year. The
key driver for growth in the fiscal ye
Copyright©2007 PR Newswire.
All rights reserved